Other Articles
- Newman Joins Vestaron as VP Finance and CFO [Monday 03 May 2010, 20:08]
- A better bug killer? Vestaron Corp.'s spider-venom pesticides could be on market by 2012 [Sunday 21 February 2010, 06:06]
- Vestaron Named "TiE Midwest 20"Winner [Wednesday 16 December 2009, 00:12]
- Elin D. Miller Elected to Vestaron Board [Wednesday 26 August 2009, 17:05]
- Venomix Changes Name to Vestaron [Wednesday 26 August 2009, 17:05]
Venomix Named Michigan Top 50 Company To Watch
Written by Administrator
Monday, 27 April 2009 21:57
KALAMAZOO, Mich., April 27 -- Venomix, Inc. has been selected as a “Michigan 50 Companies to Watch” award recipient for 2009. The award will be presented to Venomix President and CEO John L. McIntyre, Ph.D., at the 2009 Michigan Celebrates Small Business awards ceremony on April 30 at the Lansing Center in Lansing, Mich. Venomix is developing a new generation of insecticides based on the peptides spiders use to kill insects.
“We are extremely pleased to be recognized as one of Michigan’s top 50, second-stage companies,” said McIntyre. “This award is acknowledgement that our technology and business plan set us apart from the crowd of startups trying to build a business. We are truly honored.”
Venomix was incorporated in 2005 and has raised over $4.5 million through private placements. The company employs eight people at its corporate headquarters and research facilities located in the Southwest Michigan Innovation Center in Kalamazoo.
The “Michigan 50 Companies to Watch” award program recognizes second-stage startup companies that distinguish themselves by their “innovative products” and “unique processes.” The competition was created by the Edward Lowe Foundation in Cassopolis, Mich. Companies are judged for their “special strengths” which “revolve around a company's innovative products and business practices, special use of technology, work within their community and more,” according to the foundation’s website. (http://edwardlowe.org)
Venomix is developing a new generation of insecticides using peptides from spiders. The company’s technology is based on groundbreaking research conducted at the University of Connecticut. Over 50 unique, insecticidal spider peptides have been identified. This patented technology is exclusively licensed to Venomix. Products under development have a unique mode of action, are highly effective against insects and related pests and are harmless to non-target species, including humans. Target markets include agriculture, animal health and specialty non-crop uses such as household insects. Venomix products will be ideally suited for the environmentally conscious twenty-first century.
| < Prev | Next > |
|---|